Instil Bio
Dallas
About Instil Bio
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes for the treatment of solid tumor cancers. It is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its candidate and the first-in-human study of its next-generation engineered TIL.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $200.2M
- Funding stage: IPO
- Last round: Series B (Aug 2020)
- Ticker: nasdaq:TIL
- Website: instilbio.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/instil-bio-27799 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.